Issoufou I, El Alami H, Belliraj L, Harmouchi H, Ammor F Z, Lakranbi M, Ouadnouni Y, Smahi M
Service de chirurgie thoracique, CHU Hassan II, route de Sidi-Harazem, BP 1893, Km 2,200, 30000 Fès Maroc.
Service de chirurgie thoracique, CHU Hassan II, route de Sidi-Harazem, BP 1893, Km 2,200, 30000 Fès Maroc.
Rev Mal Respir. 2020 Feb;37(2):117-122. doi: 10.1016/j.rmr.2019.08.007. Epub 2020 Jan 21.
Our purpose is to evaluate our results of surgery for tracheobronchial carcinoid tumour as well as the long-term survival.
This is a retrospective and descriptive study performed in the department of thoracic surgery of CHU Hassan II (Marocco) over a period of 9 years. It concerns all patients with a tracheal or bronchial carcinoid tumour who underwent surgery.
Twenty-three patients with a mean age of 39 years were operated on for 24 carcinoid tumours. The sex ratio was 0.29. The diagnostic delay ranged from 3 months to 8 years and the main symptom was haemoptysis in 74% of cases (n=17). The tumour was localized in the right bronchial tree in 70% of cases (n=16). The procedures performed were tracheal resection and end-to-end anastomosis in 1 case, lobectomy in 12 cases including 3 sleeve lobectomies, bilobectomy of middle and lower lobes in 7 cases and pneumonectomy in 4 cases. The prognosis was favourable in 91% after an average follow-up of 29 months.
Surgery remains the only curative therapeutic option for tracheobronchial carcinoid tumours with acceptable morbidity and mortality.